Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esteban Celis

Showing results (101-110 of 121) with videos related to

Pageof 13
Sort By:
The Journal of Experimental Medicine|February 11, 2015
Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17-producing CD4+ T cellsMyrna L Ortiz, Vinit Kumar, Anna Martner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2004
Augmentation of T cell levels and responses induced by androgen deprivationAnja C Roden, Michael T Moser, Samuel D Tri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 21, 2014
Oxidized lipids block antigen cross-presentation by dendritic cells in cancerRupal Ramakrishnan, Vladimir A Tyurin, Vladimir A Tuyrin, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2021
Interruption of MDM2 signaling augments MDM2-targeted T cell-based antitumor immunotherapy through antigen-presenting machineryMichihisa Kono, Takumi Kumai, Ryusuke Hayashi, et al.
The Journal of Experimental Medicine|September 30, 2010
HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironmentCesar A Corzo, Thomas Condamine, Lily Lu, et al.
Journal of Translational Medicine|June 22, 2019
PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinomaYui Hirata-Nozaki, Takayuki Ohkuri, Kenzo Ohara, et al.
American Journal of Clinical Oncology|August 8, 2006
Peptide vaccination of patients with metastatic melanoma: improved clinical outcome in patients demonstrating effective immunizationSvetomir N Markovic, Vera J Suman, James N Ingle, et al.
Nature Communications|March 31, 2019
Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse modelRaziye Piranlioglu, EunMi Lee, Maria Ouzounova, et al.
The Journal of Clinical Investigation|November 13, 2009
PKCtheta is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in miceJavier O Valenzuela, Cristina Iclozan, Mohammad S Hossain, et al.
Head & Neck|January 31, 2012
Induction of MAGE-A3 and HPV-16 immunity by Trojan vaccines in patients with head and neck carcinomaCaroline J Voskens, Duane Sewell, Ronna Hertzano, et al.
Pageof 13

Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
The Journal of Experimental Medicine|February 11, 2015
Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17-producing CD4+ T cellsMyrna L Ortiz, Vinit Kumar, Anna Martner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2004
Augmentation of T cell levels and responses induced by androgen deprivationAnja C Roden, Michael T Moser, Samuel D Tri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 21, 2014
Oxidized lipids block antigen cross-presentation by dendritic cells in cancerRupal Ramakrishnan, Vladimir A Tyurin, Vladimir A Tuyrin, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2021
Interruption of MDM2 signaling augments MDM2-targeted T cell-based antitumor immunotherapy through antigen-presenting machineryMichihisa Kono, Takumi Kumai, Ryusuke Hayashi, et al.
The Journal of Experimental Medicine|September 30, 2010
HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironmentCesar A Corzo, Thomas Condamine, Lily Lu, et al.
Journal of Translational Medicine|June 22, 2019
PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinomaYui Hirata-Nozaki, Takayuki Ohkuri, Kenzo Ohara, et al.
American Journal of Clinical Oncology|August 8, 2006
Peptide vaccination of patients with metastatic melanoma: improved clinical outcome in patients demonstrating effective immunizationSvetomir N Markovic, Vera J Suman, James N Ingle, et al.
Nature Communications|March 31, 2019
Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse modelRaziye Piranlioglu, EunMi Lee, Maria Ouzounova, et al.
The Journal of Clinical Investigation|November 13, 2009
PKCtheta is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in miceJavier O Valenzuela, Cristina Iclozan, Mohammad S Hossain, et al.
Head & Neck|January 31, 2012
Induction of MAGE-A3 and HPV-16 immunity by Trojan vaccines in patients with head and neck carcinomaCaroline J Voskens, Duane Sewell, Ronna Hertzano, et al.
Pageof 13